Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT06723366

Protective Effect of Angong Niuhuang Against Negative Inflammatory Response and Neurologic Dysfunction After Cardiovascular Surgery

Protective Effect of Angong Niuhuang Against Negative Inflammatory Response and Neurologic Dysfunction After Cardiovascular Surgery (PANDA X)

Sponsor: Beijing Anzhen Hospital

Conditions Brain Injury Cardio-pulmonary Bypass Cardiovascular Surgery Cerebral Protection

Interventions Angong Niuhuang Pill (ANP) Control (Standard treatment)

Updated 2 times since 2025 Last updated: Dec 9, 2024 Started: Jan 1, 2025 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Brain Injury and Cardio-pulmonary Bypass and is currently actively recruiting participants. Beijing Anzhen Hospital leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Not Yet Recruiting NA
Jan 2025 — Sep 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Anzhen Hospital
Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University

Data source: Nanjing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China
• Nanjing, China